arGentis is a company headquartered in Sweden.
arGentis is an early stage biotech company focused on the commercialization of treatments for dry-eye and orphan drugs for systemic sclerosis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.